Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Daniel Lave is active.

Publication


Featured researches published by Daniel Lave.


Biochemical Pharmacology | 1987

Paf binding sites: Characterization by [3H] 52770 RP, a pyrrolo [1,2-c] thiazole derivative, in rabbit platelets

Christine Robaut; Gabrielle Durand; Claude James; Daniel Lave; Pierre Sedivy; Anne Floch; Serge Mondot; Daniel Pacot; Icilio Cavero; Gérard Le Fur

52770 RP, the N-(3-chlorophenyl)-3-(3-pyridinyl)-1H,3H-pyrrolo[1,2-c]thiazole -7-carboxamide, displaces in a potent, specific and competitive manner [3H]PAF from its binding sites on rabbit platelets. Since 52770 RP is not structurally related to PAF and has low liposolubility with respect to PAF, it was selected as a potential radioligand for PAF receptor sites. [3H]52770 RP displayed high-affinity, specificity, as well as saturable and displaceable binding to a single class of recognition sites in intact platelets and crude platelet membranes. In these preparations, the values of binding parameters were, respectively, 8.5 and 7.6 nM for Kd, 0.2 pmol/5 X 10(7) platelets and 3.66 pmol/mg protein for Bmax and 0.96 and 0.91 for nH. Inasmuch as the (+)-52770 RP was 300-fold more potent than the (-)-isomer at displacing [3H]52770 RP in intact platelets, the studied binding site manifested stereospecific discrimination. A variety of pharmacological agents including pro- and anti-aggregant compounds did not exhibit affinity for [3H]52770 RP binding sites. In contrast, PAF, some of its active analogues and several recognized PAF antagonists (BN 52021, brotizolam, L-652,731, triazolam), displaced the [3H]52770 RP binding. Studies carried out using [3H]PAF demonstrated that 52770 RP was approximately 4- and 200-fold more potent than L-652,731 and BN 52021 respectively, as a PAF-receptor antagonist. In washed rabbit platelets, the rank order of potency (Ki) for several analogues of 52770 RP, to displace [3H]PAF from its binding sites, was highly correlated (r = 0.96) to their ability to antagonize [3H]52770 RP binding. In functional studies, 52770 RP antagonized not only the PAF-induced aggregation in washed rabbit platelets but also the hypotension evoked by PAF in the anesthetized rat. In this respect, it was 26 and 2 times more potent than L-652,731, respectively. In conclusion, [3H]52770 RP might represent a novel interesting tool for furthering our understanding of the role of PAF binding sites in pathophysiological processes.


Tetrahedron Letters | 1985

Une cycloaddition dipolaire-1,3 inattendue du chloro-2 acrylonitrile

Jean-Louis Fabre; Daniel Farge; Claude James; Daniel Lave

Abstract The 1,3-dipolar cycloaddition of 2-chloroacrylonitrile on N-(2-pyridinecarbonyl) proline 1a and thio analogue 1b affords unexpected bridged compounds 2 and 3, the reactivity of which versus H2S is described.


Archive | 1987

1H,3H-pyrrolo[1,2-c]thiazole derivatives, their preparation and pharmaceutical compositions containing them

Jean-Louis Fabre; Claude James; Daniel Lave


Archive | 1984

Derivatives of 1H,3H-pyrrolo(1,2-c)thiazole, their preparation and pharmaceuticals containing them

Jean-Louis Fabre; Daniel Farge; Claude James; Daniel Lave


Archive | 1984

Anti-thrombotic ortho-condensed pyrrole derivatives, compositions, and method of use therefor

Jean-Louis Fabre; Daniel Farge; Claude James; Daniel Lave


Archive | 1984

Ortho-condensed pyrrole derivatives, their preparation and medicaments containing them

Jean-Louis Fabre; Daniel Farge; Claude James; Daniel Lave


Archive | 1990

1H,3H,7-pyrrolo [1,2-c] thiazolecarboxamides, their preparation and pharmaceutical compositions containing them

Claude James; Daniel Lave; Francoise Soler


Archive | 1987

1H,3H-pyrrol[1,2-c]thiazole derivatives and pharmaceutical compositions containing them

Jean-Louis Fabre; Claude James; Daniel Lave


Archive | 1984

Heterocyclic compounds, process for their preparation and medicines containing them

Jean-Louis Fabre; Daniel Farge; Claude James; Daniel Lave


Archive | 1984

Pyrrolo[1,2-c]thiazoles useful as antithrombotic agents

Jean-Louis Fabre; Daniel Farge; Claude James; Daniel Lave

Collaboration


Dive into the Daniel Lave's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge